PTX 0.00% 4.1¢ prescient therapeutics limited

Ann: Trading Halt, page-208

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 141 Posts.
    lightbulb Created with Sketch. 28
    Im starting to wonder if the 'material licensing agreement' we are expecting might be another like this one from 2015:

    https://wholesaleinvestor.com.au/prescient-therapeutics-acquires-exclusive-worldwide-licence-for-cancer-biomarker-p27/

    In the above case, the term 'material' referred to the size of the payment PTX made to Moffit cancer centre for IP and licensing rights to enable them to continue their clinical research.

    Could this announcement in effect be as simple as money going out rather than in, to further support and advance PTX's clinical development?
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.1¢
Change
0.000(0.00%)
Mkt cap ! $33.01M
Open High Low Value Volume
4.1¢ 4.2¢ 4.1¢ $2.562K 62.14K

Buyers (Bids)

No. Vol. Price($)
5 269907 4.1¢
 

Sellers (Offers)

Price($) Vol. No.
4.2¢ 19000 2
View Market Depth
Last trade - 15.59pm 11/11/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.